Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Celerion announced the launch of the latest version of Labnotes, its bioanalytical electronic laboratory notebook software for data handling and analysis capabilities for sponsors.
read more
Celerion is pleased to announce the expansion of clinical operations to South
Korea. Through partnership with Seoul National University Hospital (SNUH), the new Asian office is located
within the SNUH Clinical Trials Center. This enables Celerion ...
read more
Thursday, November 10, 2022
Celerion is expanding its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the development of new gene and cell therapies.
read more
Celerion announced the launch of on-site services for rapid sterility testing (validated alternative method to USP <71>) and dose formulation analysis.
read more
Tuesday, November 29, 2016
GNS Healthcare (GNS), a precision medicine company that applies causal machine learning technology to massive and diverse data streams to better match drugs and other health interventions to individual patients, has announced that Celgene Corporation...
read more
Wednesday, August 23, 2023
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organization specializing in the advancement of cell and gene therapies, announces a collaboration with Rentschler Biopharma, a leading global contract ...
read more
The Cell and Gene Therapy Catapult (CGT Catapult) announced it has licensed data from its pluripotent stem cell development program ‘Cell Plasticity’ to Japanese food and amino acid company Ajinomoto.
read more
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
read more
Thursday, November 10, 2016
Cell Culture Company (C3), a biopharmaceutical developer and manufacturer, has entered into an agreement with a China-based joint venture to produce a clinical-grade antibody-based therapeutic vaccine targeting pancreatic cancer.
read more
Wednesday, November 11, 2020
Cell Guidance Systems announced the launch of a new product for the purification of exosomes from blood and other samples.
read more
Cell Medica announced the acquisition of Catapult Therapy TCR, a subsidiary of Cell and Gene Therapy Catapult, and the initiation of a collaboration to establish cell therapy manufacturing for Cell Medica at CGT Catapult’s GMP manufacturing facility ...
read more
Cellares, an first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that Bristol Myers Squibb has joined its Technology Adoption Partnership (TAP) program.
read more
Cellaria, LLC has announced the expansion of its offerings to include a suite of stem cell services. The initiative advances Cellaria’s mission to provide more accurate patient and disease-specific cell models to help researchers focus and accelerate...
read more
Cellaria announced a new sales and marketing agreement with Biological Industries to promote custom stem cell services.
read more
Cellbox Solutions is pleased to announce the opening of its new headquarters in Norderstedt, which is located nearby Hamburg, Germany.
read more